Literature DB >> 17097359

Biomarker discovery from body fluids using mass spectrometry.

Ana Villar-Garea1, Matthias Griese, Axel Imhof.   

Abstract

Systems analysis of body fluids by mass spectrometry (MS) is an upcoming field of biomarker research. This approach is extremely attractive because it does not require biomarker candidates and the sample preparation is simple. However, during the development of the technique strong critical comments were made on the poor reproducibility, the special characteristics of blood as a source of peptides and on the frequent non-adequate statistical analysis of the data. Here we discuss the efforts made in the last few years to develop suitable protocols, which could lead to biomarker discovery from body fluids by mass spectrometry. Our review focuses on the systems analysis of non-digested blood serum or plasma samples by MALDI-TOF and SELDI-TOF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097359     DOI: 10.1016/j.jchromb.2006.09.017

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

Review 1.  Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Authors:  Fulvio Magni; Yuri E M Van Der Burgt; Clizia Chinello; Veronica Mainini; Erica Gianazza; Valeria Squeo; André M Deelder; Marzia Galli Kienle
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 2.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

3.  Sputter deposited bioceramic coatings: surface characterisation and initial protein adsorption studies using surface-MALDI-MS.

Authors:  A R Boyd; G A Burke; H Duffy; M Holmberg; C O' Kane; B J Meenan; P Kingshott
Journal:  J Mater Sci Mater Med       Date:  2010-11-21       Impact factor: 3.896

Review 4.  Metabolomics-based methods for early disease diagnostics.

Authors:  G A Nagana Gowda; Shucha Zhang; Haiwei Gu; Vincent Asiago; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

5.  Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.

Authors:  K Wada-Isoe; K Michio; K Imamura; K Nakaso; M Kusumi; H Kowa; K Nakashima
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

6.  Association between protein signals and type 2 diabetes incidence.

Authors:  Troels Mygind Jensen; Daniel R Witte; Damiana Pieragostino; James N McGuire; Ellis D Schjerning; Chiara Nardi; Andrea Urbani; Mika Kivimäki; Eric J Brunner; Adam G Tabàk; Dorte Vistisen
Journal:  Acta Diabetol       Date:  2012-02-05       Impact factor: 4.280

7.  In vitro toxicity of melamine against Tetrahymena pyriformis cells.

Authors:  Zhengfang Wang; Liben Chen; Rashad Al-Kasir; Bo Han
Journal:  J Vet Sci       Date:  2011-03       Impact factor: 1.672

8.  Human coelomic fluid investigation: A MS-based analytical approach to prenatal screening.

Authors:  Donatella Aiello; Antonino Giambona; Filippo Leto; Cristina Passarello; Gianfranca Damiani; Aurelio Maggio; Carlo Siciliano; Anna Napoli
Journal:  Sci Rep       Date:  2018-07-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.